Stay updated with breaking news from Opgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
OpGen, Inc. (NASDAQ:OPGN – Get Rating) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 545,300 shares, a growth of 272.5% from the February 28th total of 146,400 shares. Based on an average daily volume of 446,000 shares, the short-interest ratio is currently 1.2 days. Approximately […]
OpGen, Inc. (NASDAQ:OPGN – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 545,300 shares, an increase of 272.5% from the February 28th total of 146,400 shares. Based on an average daily volume of 446,000 shares, the days-to-cover […]
Investment analysts at StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Get Rating) in a report released on Wednesday. The brokerage set a “sell” rating on the medical research company’s stock. A number of other research firms have also issued reports on OPGN. Alliance Global Partners lowered OpGen to a “neutral” rating in a […]
OpGen (NASDAQ: OPGN) has recently received a number of price target changes and ratings updates: 6/18/2022 – OpGen is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/10/2022 – OpGen is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/10/2022 – OpGen had […]
Several brokerages have updated their recommendations and price targets on shares of OpGen (NASDAQ: OPGN) in the last few weeks: 6/3/2022 – OpGen was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping […]